|
|
Until about five years ago, the very idea that peptide hormones might be
made anywhere in the brain besides the hypothalamus was astounding. Peptide
hormones, scientists thought, were made by endocrine glands and the hypothalamus
was thought to be the brains’ only endocrine gland. What is more, because
peptide hormones cannot cross the blood-brain barrier, researchers believed that
they never got to any part of the brain other than the hypothalamus, where they
were simply produced and then released into the bloodstream.
But these beliefs about peptide hormones were questioned as laboratory
after laboratory found that antiserums to peptide hormones, when injected into
the brain, bind in places other than the hypothalamus, indicating that either
the hormones or substances that cross-react with the antiserums are present. The
immunological method of detecting peptide hormones by means of antiserums,
however, is imprecise. Cross-reactions are possible and this method cannot
determine whether the substances detected by the antiserums really are the
hormones, or merely close relatives. Furthermore, this method cannot be used to
determine the location in the body where the detected substances are actually
produced.
New techniques of molecular biology, however, provide a way to answer these
questions. It is possible to make specific complementary DNA’s (c DNA’s) that
can serve as molecular probes seek out the messenger RNA’s (mRNA’s) of the
peptide hormones. If brain cells are making the hormones, the cells will contain
these mRNA’s. If the products the brain cells make resemble the hormones but are
not identical to them, then the c DNA’s should still bind to these mRNA’s, but
should not bind as tightly as they would to m RNA’s for the true hormones. The
cells containing these mRNA’s can then be isolated and their mRNA’s decoded to
determine just what their protein products are and how closely the products
resemble the true peptide hormones.
The molecular approach to detecting peptide hormones using cDNA probes
should also be much faster than the immunological method because it can take
years of tedious purifications to isolate peptide hormones and then develop
antiserums to them. Roberts, expressing the sentiment of many researchers,
states: “I was trained as an endocrinologist. But it became clear to me that the
field of endocrinology needed molecular biology input. The process of grinding
out protein purifications is just too slow.”
|
|